US20040015043A1 - Temporary heart assist system - Google Patents
Temporary heart assist system Download PDFInfo
- Publication number
- US20040015043A1 US20040015043A1 US10/603,669 US60366903A US2004015043A1 US 20040015043 A1 US20040015043 A1 US 20040015043A1 US 60366903 A US60366903 A US 60366903A US 2004015043 A1 US2004015043 A1 US 2004015043A1
- Authority
- US
- United States
- Prior art keywords
- patient
- balloon
- extra
- pump
- corporeal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/205—Non-positive displacement blood pumps
- A61M60/216—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller
- A61M60/226—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller the blood flow through the rotating member having mainly radial components
- A61M60/232—Centrifugal pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/104—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
- A61M60/135—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel inside a blood vessel, e.g. using grafting
- A61M60/139—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel inside a blood vessel, e.g. using grafting inside the aorta, e.g. intra-aortic balloon pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/205—Non-positive displacement blood pumps
- A61M60/216—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller
- A61M60/237—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller the blood flow through the rotating member having mainly axial components, e.g. axial flow pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/295—Balloon pumps for circulatory assistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/40—Details relating to driving
- A61M60/497—Details relating to driving for balloon pumps for circulatory assistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/50—Details relating to control
- A61M60/508—Electronic control means, e.g. for feedback regulation
- A61M60/515—Regulation using real-time patient data
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/50—Details relating to control
- A61M60/508—Electronic control means, e.g. for feedback regulation
- A61M60/515—Regulation using real-time patient data
- A61M60/531—Regulation using real-time patient data using blood pressure data, e.g. from blood pressure sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3303—Using a biosensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/04—Heartbeat characteristics, e.g. ECG, blood pressure modulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/30—Blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/247—Positive displacement blood pumps
- A61M60/253—Positive displacement blood pumps including a displacement member directly acting on the blood
- A61M60/268—Positive displacement blood pumps including a displacement member directly acting on the blood the displacement member being flexible, e.g. membranes, diaphragms or bladders
- A61M60/274—Positive displacement blood pumps including a displacement member directly acting on the blood the displacement member being flexible, e.g. membranes, diaphragms or bladders the inlet and outlet being the same, e.g. para-aortic counter-pulsation blood pumps
Definitions
- cardiac assist devices Many types have been developed over the past 40 years.
- the general types of devices can be characterized as short-term (hours to days), bridge-to-transplantation, bridge-to-recovery, and permanent or long-term.
- the goal of these devices is to mechanically support the failing heart by increasing systemic perfusion, and/or reducing the workload of the failing heart, thus creating the most favorable environment for cardiac recovery.
- IABP intra-aortic balloon pump
- the basic components of the intra-aortic balloon pump are a catheter tipped with a long balloon and a pump console that shuttles helium gas through the catheter to inflate and deflate the balloon synchronously with the heart beat.
- the balloon is inserted into an artery and guided to a position in the descending thoracic aorta just distal to the left subclavian artery.
- the pump control console contains signal processing, drive, timing, and control mechanisms for appropriate inflation and deflation.
- the IABP is rapidly deflated, reducing the workload and oxygen demands of the heart by decreasing the resistance to blood flow from the ventricle.
- the IABP is rapidly inflated counter-pulsation increasing aortic and coronary perfusion pressures. Timing of the inflation-deflation cycle is based on the electrocardiogram and arterial blood pressure waveform.
- the present invention relates generally to methods and devices for mechanically assisting the failing heart. More specifically, it relates to balloon catheters and bypass pumps.
- Aortic occlusion balloons are known in the prior art. Such aortic balloons are non co-pulsating with the heartbeat and are not employed with an aortic bypass pump. The following patents disclose aortic occlusion balloons.
- Aortic bypass pumps are known in the prior art. Aortic bypass pumps are not employed with a co-pulsating aortic occlusion balloon for heart assistance.
- the following patents disclose aortic bypass pumps. The full disclosures of these patents are all incorporated herein by this reference: 6,299,575 Implantable heart assist system 6,200,260 Implantable heart assist system 5,749,855 Catheter pump 4,968,293 Circulatory assist device
- a preferred embodiment of the present invention provides a method and a system to temporarily assist the failing heart.
- the temporary heart-assist system comprises an occluding device positionable in the patient's descending aorta.
- the occluding device may or may not include a pressure sensor that electrically couples to an extra-corporeal controller.
- the occluding device itself also couples pneumatically to the extra-corporeal controller.
- the pump inlet of an extra-corporeal pump is connectable via a cannula to a patient's supra-diaphragmatic artery.
- the pump outlet of the extra-corporeal pump is connectable via a cannula to a patient's infra-diaphragmatic artery.
- a doctor inserts into the patient the occluding device via a peripheral artery into the descending aorta, and positions the occluding device near the level of the patient's diaphragm.
- the occluding device catheter coupled to the extra-corporeal controller, inflates and deflates the occluding device.
- the electrocardiogram ECG and proximal aortic blood pressure measured in the upper arterial compartment via a lumen in the occluding device catheter, serve as inputs to cycle the occluding device synchronously with the heartbeat.
- the step of inflating occurs just prior to the start of cardiac systole co-pulsation and ventricular ejection.
- the extra-corporeal pump continuously or cyclically pumps blood from a supra-diaphragmatic-artery to a infra-diaphragmatic artery.
- the pumping flow rate varies in response to the end-systolic pressure measured in the upper arterial compartment of the patient's body.
- the step of deflating the aortic balloon occurs at the start of cardiac diastole and aortic valve closure. Deflating the balloon stabilizes the perfusion pressure between the upper and lower arterial compartments.
- the method of the present invention pumps blood from the patient's upper to the patient's lower arterial compartments.
- the present invention is designed to temporarily assist the failing human heart for a period of several hours to several days.
- the objectives of the heart-assist system of the present invention are to augment cardiac output and enhance systemic perfusion, reduce the workload and oxygen requirements of the acutely failing heart and allow for its recovery, allow for optimization of concomitant drug therapy, require minimal surgical intervention for insertion and removal, and reduce additional trauma to the failing heart by eliminating a need for direct cannulation of the left atrium or left ventricle.
- An additional feature of this technology is enhancement of diastolic perfusion by elevation of pressure throughout the diastolic interval and, unlike a commercially available balloon pump, enhancement of perfusion to all organs.
- the present invention allows for treatment of the failing heart in a minimally invasive manner with augmentation of left ventricular stoke volume cardiac output and simultaneous reduction in left ventricular workload and oxygen requirements of the heart.
- An important feature of the invention is that it rapidly inflates a small-volume balloon, partially occluding the aorta just prior to the start of cardiac systole and ventricular ejection.
- it regulates aorta-aorta bypass blood pump flow to obtain a specific end-systolic aortic pressure measured in the upper arterial compartment.
- decreasing end-systolic aortic pressure results in an increased ventricular stroke volume based on the ventricular pressure-volume-contractility relationship. Decreased systolic pressure also reduces the workload on the failing heart.
- Increased bypass pump blood flow elevates perfusion pressure in the lower arterial compartment.
- the system rapidly deflates an aortic balloon at end-systole. Deflating the aortic balloon stabilizes the perfusion pressure between the upper and lower arterial compartments.
- FIG. 1 depicts an overview of the temporary heart-assist system, illustrating the intra-aortic balloon, aortic-aortic external bypass pump, and external controller, as installed on a patient.
- FIG. 2 is a detailed view of the intra-aortic balloon and associated catheter, illustrating some of their features.
- FIG. 3A is a schematic of the temporary heart-assist system, illustrating the intra-aortic balloon, aortic-aortic external bypass pump, and external controller, as installed on a patient.
- FIG. 3B is a schematic of a human heart, depicting part of an inlet catheter with the tip of the catheter positioned through the aortic valve into the left ventricle.
- FIG. 4 is a graph of the left ventricular-pressure-volume-contractility relationships for the normal heart, failing heart, and failing heart supported with the temporary heart-assist system according to the present invention.
- FIG. 5A is a graph showing the electrocardiogram and aortic blood pressures of the failing heart.
- FIG. 5B and FIG. 5C are graphs showing the electrocardiogram, aortic blood pressures, aortic balloon inflation/deflation timing, and bypass pump flow rate or motor speed with the temporary heart-assist system operating.
- FIG. 6A is a schematic of the external control unit illustrating manual controls, transducer inputs, monitor display, aortic balloon pneumatics, and bypass pump electronics.
- FIG. 6B is a schematic of the assist timing control panel, illustrating the method for setting the inflation and deflation timing of the aortic balloon.
- FIG. 6C is a schematic of the pressure assist control panel, illustrating the method for setting the degree of systolic pressure unloading of the heart.
- FIG. 6D is a detailed graph showing the control-logic loop for the heart assist system.
- FIG. 1 a temporary heart-assist system 7 is illustrated in use with a human heart.
- the heart-assist system 7 includes an occluding device, or balloon, 8 in the patient's aorta, connected to a controller 9 , Which in turn connects to an extracorporeal aortic bypass blood pump 10 .
- the occluding device 8 can be any device that can be remotely opened and closed, either partially or fully, but in the preferred embodiment is a balloon.
- U.S. Pat. Nos. 5,894,273 and 6,137,416 disclose a limited-use controller that does not control an intra-aortic valve, such as the balloon 8 .
- the deflated balloon 8 is mounted on the end of a flexible catheter 11 .
- the balloon 8 and catheter 11 are inserted into the aorta via a peripheral artery, preferably at a point 12 on the femoral artery.
- the catheter 11 may be inserted percutaneously over a guide wire or surgically by direct exposure of the vessel.
- the balloon 8 is positioned in the descending thoracic aorta at approximately the level of the diaphragm. More specifically, the balloon 8 is placed above the diaphragm, but below the subclavian artery.
- the aortic blood pressure AoP is recorded with two pressure transducers, or sensors 13 on the balloon 8 .
- the pressure transducers 13 are conventional transducers, such as model number BP01, manufactured by the InvenSys Company located in Milpitas, Calif.
- the controller 9 allows sustained flow to pump and reads upper and lower pressure for pump adjustments from the balloon sensors 13 .
- the balloon sensors 13 monitor pressure, and when pressure goes up then pump flow increases, and vice versa.
- the principle of the balloon 8 is to equalize pressure during systole, and to auto-regulate the flow rate of the pump 10 , based on the pressure sensed by the pressure sensors 13 on either side of the balloon 8 .
- the balloon 8 inflates as the aortic valve opens and deflates upon closure. If timed properly, there should be no period in which the aortic valve is closed and the balloon 8 inflated. In an alternate embodiment, only one sensor 13 is used.
- the catheter 11 has duel lumens.
- a larger lumen 14 is used to shuttle gas to and from the balloon 8 via openings or ports 15 located on a catheter wall.
- a smaller lumen 16 runs continuously through the body of the catheter 11 .
- the smaller lumen 16 is used for inserting the catheter 11 over an aortic guide wire and as a pressure transmission tube for the continuous measurement of central aortic pressure AoP proximal to the balloon 8 during operation of the heart-assist system 10 .
- the balloon 8 and catheter 11 are made of biocompatible polymeric materials.
- the balloon 8 and catheter 11 are flexible and nontraumatic to the aorta, but have a wall thickness and strength sufficient to withstand cyclic rapid balloon inflation and deflation.
- the pressure transducers 13 connect to the pressure transmission tube lumen 16 .
- the lumen 16 couples to a cable 18 that connects to the controller 9 .
- the balloon 8 is inflated and deflated by gas pressure, preferably using helium gas, supplied through a pneumatic tube 20 attached to the large lumen 14 .
- the tube 20 connects to the controller 9 .
- the balloon 8 deflates when depressurized with gas, and inflates when pressurized with gas, thereby partially or fully occluding the aorta. To avoid stagnation of the blood and vessel trauma, the balloon 8 does not need to completely occlude the descending aorta; it may leave some space on either side.
- FIG. 3A the left ventricle 22 of the heart is shown in systole with ejection of blood (long arrow) through the opened aortic outflow valve 24 into the ascending aorta 26 .
- An inlet cannula 38 for the pump 10 is inserted into the aorta at a point 40 proximal to the balloon 8 , using conventional surgical techniques.
- the point 40 may be in the ascending aorta 26 , for patients who have an open chest, or may be in a branch vessel, preferably the subclavian artery, for patients whose chest is not open, or at any point between.
- the length of the inlet cannula 38 extends with its tip positioned through the aortic valve 24 into the left ventricle 22 .
- Holes 39 along the length of the inlet cannula 38 in the aorta, combined with a hole 39 in the tip of the cannula 38 provide direct unloading of the left ventricle 22 , plus afterload reduction in the aorta.
- the lumen of the inlet cannula 38 is of sufficient size and capacity to allow flow rates (see arrow) up to 7 liters per minute, with minimal pressure drop and blood destruction hemolysis.
- U.S. Pat. No. 6,007,478 discloses a cannula having constant wall thickness with increasing distal flexibility. The full disclosure of this patent is incorporated herein by this reference.
- the inlet cannula 38 is brought out of the patient and connected to the pump 10 .
- the pump 10 is a commercially available non-pulsatile blood pump.
- Artificial heart pumps can be classified into the diaphragm type, the tube type, the roller pressure type, and the radial flow type that operates by rotational motion. Typical of the radial flow type is the centrifugal type.
- centrifugal heart pumps 5,894,273 Centrifugal blood pump driver apparatus 6,015,434 Artificial heart pump 6,137,416 Method of controlling centrifugal pump 6,227,817 Magnetically-suspended centrifugal blood pump
- the pump 10 may be any radial pump, but in the preferred embodiment the pump 10 is a centrifugal pump.
- a drive motor 42 powers the pump 10 via a magnetic coupling 44 located between the drive motor 42 and the pump 10 .
- the pump 10 has the capacity to pump up to 7 liters per minute of blood without increased hemolysis or thrombosis clot formation.
- Pump flow rate is continuously measured using a conventional flow transducer 45 connected to the controller 9 .
- the transducer 45 may be of the ultrasonic or electromagnetic type, but in the preferred embodiment is an ultrasonic model, made by Transonic Systems, Inc., located in Ithaca, N.Y.
- the point 48 is in the femoral artery.
- the lumen of the outlet cannula 46 is of sufficient size and capacity to allow flow rates up to 7 liters per minute, with minimal pressure drop and hemolysis.
- ECG electrocardiogram
- the pump drive motor 42 couples to the controller 9 via a cable 62 .
- the purpose of the pump 10 is to pump blood from the upper arterial compartment 14 to the lower arterial compartment.
- the small-volume balloon 8 is rapidly inflated, partially occluding the aorta.
- the flow rate of the pump 10 is regulated to obtain a specific end-systolic AoP in the upper arterial compartment (aorta 26 ).
- the pump runs continuously at a set speed. A deceased end-systolic aortic pressure afterload results in an increase in cardiac output blood flow.
- Decreased afterload also reduces the workload and oxygen consumption of the failing heart.
- Increased systemic blood flow also elevates perfusion pressure in the lower arterial compartment.
- the balloon 8 rapidly deflates, thereby increasing the perfusion pressure throughout the arterial compartment 26 .
- the pump flow rate can also be slowed during diastole by coasting or braking the motor 42 , thereby reducing the potential for blood trauma hemolysis. Decreasing pump flow may be obtained by coasting or braking the speed of the centrifugal pump motor.
- the pump 10 runs continuously at a set speed.
- the y-axis shows ventricular pressure 0-120 mmHg
- the x-axis shows ventricular volume 0-210 ml.
- the aortic valve closes and pressure decreases as the walls of the ventricle relax during diastole.
- the left ventricle fills from the left atrium, containing oxygenated blood from the lungs, and ventricular volume increases.
- Contractility strength of contraction of the normal ventricle may be defined by the slope of the end-systolic pressure ESP-volume ESV relationship shown as solid line CN.
- the contractility slope shown as dashed line CF is reduced and the EDV is increased.
- the cardiac stroke volume is reduced due to decreased contractility slope.
- the ventricle is more sensitive to changes in the ESP. Otherwise stated, with heart failure small changes in ESP lead to larger changes in ESV compared to the normal ventricle.
- FIG. 4 also illustrates the effects of the embodiments of the present invention on the failing heart.
- the left ventricle is pressure and volume unloaded.
- the aortic balloon 8 is inflated, occluding the aorta, and the bypass blood pump 10 transfers blood from the upper arterial compartment to the lower arterial compartment.
- Pump flow rate is controlled increased or decreased to result in a set ESP level.
- the reduced ESP during mechanical assistance results in a reduced ESV loop F 2 despite an unchanged contractility slope dashed line CF.
- reducing ESP and ESV with the heart-assist system 7 will increase cardiac stroke volume systemic perfusion and may also decrease ventricular EDV.
- Pressure and volume unloading of the ventricle also decreases systolic ventricular wall tension a primary component of cardiac muscle oxygen consumption.
- the aortic balloon 8 and aortic bypass pump 10 are synchronously operated using the ECG-triggered and pressure-feedback controller 9 .
- the small-volume balloon 8 is rapidly inflated, partially occluding the aorta.
- the flow rate of the aortic bypass blood pump 10 is regulated to obtain a specific end-systolic aortic pressure in the upper arterial compartment.
- a decreased end-systolic aortic pressure provided by the blood pump results in ventricular unloading and augmentation of systemic perfusion (stroke volume and cardiac output).
- the pump 10 assumes the circulation to the lower half of the body and the weakened heart is responsible for the upper half of the body only. Decreased afterload also reduces the workload on the failing heart.
- the increased systemic blood flow elevates perfusion pressure in the lower half of the body.
- the balloon is deflated and the pump-generated pressure and flow increases the perfusion pressure throughout the arterial tree.
- the invention provides greater augmentation of systemic perfusion, improved direct ventricular unloading, and increased diastolic perfusion, and without direct cannulation of the left ventricle or atrium as required for cardiac bypass devices.
- the pump 10 Because of aortic occlusion, the pump 10 flows from high pressure to lower pressure and will actually assume about 60% of the work. It is important to note that the pump 10 makes diastole become active. The pump 10 achieves systolic unloading by augmenting flow and increased blood flow during diastolic which reduces load to the heart.
- FIG. 5A and 5 b illustrate the functioning of the heart-assist system 7 .
- FIG. 5A shows the ECG and AoP for the heart failure condition with the assist system 7 off.
- the ECG is recorded from skin electrodes appropriately placed on the patient.
- the R-wave 75 of the ECG corresponds with the start of ventricular systole and is used as a control trigger.
- the AoP shows the pressure recorded in the proximal aorta solid line and distal aorta dashed line. With the assist system off and the aortic balloon deflated, the proximal and distal aortic pressures are essentially equal.
- the start of systole 78 corresponds with the EDP time.
- the end of systole 79 corresponds with the ESP time.
- the systolic period S is when left ventricular ejection into the aorta occurs.
- the diastolic period D is when the ventricle relaxes and coronary perfusion occurs.
- the aortic balloon is activated in two stages: inflation during ventricular systole S and deflation during cardiac diastole D.
- the R-wave of the ECG is used to trigger balloon inflation.
- the start of balloon inflation 90 is controlled to obtain a preset EDP level measured in the proximal aorta using the pressure transmission lumen 16 of the aortic catheter 11 .
- the balloon 8 makes uniform and firm contact with the inside wall of the aorta. This has the effect of blocking the downstream flow of blood in the aorta during systole.
- a closed volume is created between the outflow valve of the ventricle and the expanded balloon 8 .
- the aortic bypass pump shunts blood from the upper arterial compartment proximal aorta to the lower arterial compartment distal aorta.
- the centrifugal blood pump flow rate and RPM are regulated by the external controller 9 to obtain a preset ESP level measured in the aorta proximal to the inflated balloon.
- the proximal aortic pressure is decreased solid line 80 and the distal aortic pressure is increased dashed line 82 during systole S compared to the unassisted condition shown in FIG. 5A.
- the aortic balloon is rapidly deflated 92 .
- the aorta is opened between the upper and lower arterial compartments, and the two pressures equilibrate.
- the equilibration results in increased proximal solid line 84 and distal dashed line 86 aortic pressures during diastole D compared to the unassisted condition illustrated in FIG. 5A. Therefore, the heart-assist system described in the present invention is capable of increasing cardiac stroke volume and systemic perfusion, reducing ventricular workload and oxygen consumption, and increasing perfusion pressure to the coronary arteries supplying the heart. Also shown in FIG. 5B and FIG.
- the flow rate and RPM of the centrifugal aortic-aortic bypass pump may be increased 94 at the time to correspond 95 with aortic balloon inflation 90 . This provides for maximum pressure and volume unloading of the ventricle 80 and augmentation of distal perfusion pressure 82 . Additionally, the flow rate and RPM of the centrifugal blood pump may be decreased 97 at the time to correspond 98 with aortic balloon deflation 92 . The reduced flow rate may decrease the degree of pump-induced hemolysis.
- FIG. 6A illustrates the components of the heart-assist system control unit 9 .
- Manual controls 100 are used to set the timing of balloon inflation and deflation, and to set the degree of pressure assist provided by the centrifugal blood pump.
- the control unit contains preamplifiers 102 with EKG 52 , aortic pressure 18 , and pump flow 45 inputs.
- Control setting and transducer signals are passed through an A/D converter 104 with before being sent to the processor unit 106 and monitor display subsystem 108 .
- the processor unit controls and monitors the pneumatic subsystem 110 that provides gas pressure and vacuum to inflate and deflate the aortic balloon, respectively, via a pneumatic drive line 20 .
- Processor unit 106 contains a microprocessor such as a Motorola 68HC11, random access memory (RAM) and program memory (PROM) which contains software to control the system.
- the processor unit also controls and monitors the motor control subsystem 112 , that sends power to the centrifugal blood pump drive motor via a electronic cable 64 .
- FIG. 6B illustrates the timing control panel 114 , on the external control unit, that is used for setting aortic balloon AoB inflation 116 and deflation 118 timing with respect to the R-wave of the electrocardiogram 75 as a percentage of the R-R time interval.
- the aortic balloon inflation time is established by manually moving the slide control 120 that controls a cursor line 122 simultaneously shown on the monitor display 108 .
- the slide control is moved such that the cursor line corresponds with end-diastole ED and the ED pressure 124 overlying the displayed aortic pressure waveform 126 .
- balloon deflation time is established by manually moving the slide control 128 that controls a second cursor line 130 on the display monitor.
- the slide control is moved such that the cursor line corresponds with end-systole ES and the ES pressure 132 for the aortic pressure waveform.
- the assist pump and balloon should be turned off and the inflation and deflation timing reestablished.
- FIG. 6C illustrates the pressure assist Pa control panel 140 , on the external control unit, that is used for setting the degree of ventricular unloading provided by the aortic bypass pump.
- the degree of ventricular unloading is determined by the measured difference between the aortic end diastolic pressure EDP 142 and the end systolic pressure ESP 144 .
- a control knob 146 is manually set to establish the degree of pressure unloading which ranges from a negative 5 mmHg to a positive 5 mmHg.
- a setting of ⁇ 5 corresponds with the ESP being 5 mmHg less than the corresponding EDP. This setting provides the maximum level of ventricular unloading and heart assist.
- a setting of +5 corresponds with the ESP being 5 mmHg more than the EDP. This setting provides the minimum level of ventricular unloading and is used for weaning from the heart assist system.
- the illustrated control method allows for beat-to-beat control of pump flow rate regardless of changes in the systemic vascular resistance and blood pressure.
- a manual push button 148 must be depressed simultaneously with changing the control knob setting. This method is used to prevent inadvertent changes in the pressure assist setting.
- FIG. 6D is a detailed flow diagram of the heart-assist system control logic 150 .
- Beat to beat control of the aortic occlusion balloon and aortic bypass pump is started with electrocardiogram R-wave detection 152 .
- R-wave detection the timing clock and monitor displays are reset and the preceding R-R interval time is measured 154 .
- the ED and ES times in seconds is calculated 158 for the measured R-R interval 154 .
- Aortic balloon inflation IT and deflation DT times 160 are calculated by subtracting a known electromechanical delay time for the pneumatic subsystem from the previously calculated ED and ES times 158 , respectively.
- a trigger signal 162 is sent to the pneumatic subsystem 110 to provide drive gas to the aortic balloon.
- the ED pressure EDP is measured 164 from the aortic pressure input signal.
- a trigger signal 170 is sent to the pneumatic subsystem 110 to exhaust drive gas from the aortic balloon.
- the ES pressure ESP is measured 172 from the aortic pressure input signal.
- the bypass pump speed RPM change is determined 176 based on the calculated Pdif 174 . Positive Pdif values result in increasing pump speeds. Conversely, negative Pdif values result in decreasing pump speeds.
- a speed control change signal 178 is sent to the motor control subsystem 112 which regulates centrifugal pump flow. Following the above steps, the control logic unit waits for the next R-wave detection 180 .
- the invention provides a method and apparatus for assisting the failing heart until such time that ventricular recovery and weaning from the assist system occurs.
- the invention is particularly useful in increasing cardiac output and decreasing ventricular loading without direct cannulation of the left atrium or left ventricle.
- the method includes controlled intermittent occlusion of the aorta synchronously with the cardiac cycle, accompanied by the pumping of blood from the proximal to the distal aorta at a rate sufficient to pressure and volume unload the failing left ventricle.
- Systolic ventricular unloading increases cardiac output and decreases myocardial oxygen demands.
- Augmented cardiac output levels also increase perfusion of the coronary arteries supplying oxygenated blood to the heart.
Abstract
A balloon is positionable in the patient's descending aorta. The balloon includes a balloon catheter and two pressure sensors that electrically couple to an extra-corporeal controller. The balloon itself also couples pneumatically to the extra-corporeal controller. An extra-corporeal pump electrically couples to the extra-corporeal controller, the pump having an outlet connectable to the patient's infra-diaphragmatic artery. The pump inlet is connectable via a cannula to the patient's supra-diaphragmatic artery.
A doctor inserts the balloon into the descending aorta, and positions the balloon near the level of the patient's diaphragm. A balloon catheter, coupled to the extra-corporeal controller, inflates and deflates the balloon. An electrocardiogram ECG and proximal aortic blood pressure, measured in the upper arterial compartment via a lumen in the balloon catheter, serve as inputs to cycle the balloon synchronously with the heartbeat.
Description
- This application is a divisional of application Ser. No. 10/106,744, filed Mar. 26, 2002, and is hereby incorporated herein by reference.
- Not Applicable.
- Not Applicable.
- Many types of cardiac assist devices have been developed over the past 40 years. The general types of devices can be characterized as short-term (hours to days), bridge-to-transplantation, bridge-to-recovery, and permanent or long-term. The goal of these devices is to mechanically support the failing heart by increasing systemic perfusion, and/or reducing the workload of the failing heart, thus creating the most favorable environment for cardiac recovery.
- Short-term devices are used on patients whose hearts have sustained a serious injury but can recover if adequately supported. The most commonly used short-term device is the intra-aortic balloon pump (“IABP”). Indications for employment of the IABP include cardiogenic shock or severe heart failure secondary to acute myocardial infarction or following open-heart surgery, unstable angina resistant to drug therapy, and refractory ventricular irritability after myocardial infarction. *
- The basic components of the intra-aortic balloon pump (“IABP”) are a catheter tipped with a long balloon and a pump console that shuttles helium gas through the catheter to inflate and deflate the balloon synchronously with the heart beat. The balloon is inserted into an artery and guided to a position in the descending thoracic aorta just distal to the left subclavian artery. The pump control console contains signal processing, drive, timing, and control mechanisms for appropriate inflation and deflation. During cardiac systole ventricular contraction and ejection, the IABP is rapidly deflated, reducing the workload and oxygen demands of the heart by decreasing the resistance to blood flow from the ventricle. During cardiac diastole ventricular relaxation and filling, the IABP is rapidly inflated counter-pulsation increasing aortic and coronary perfusion pressures. Timing of the inflation-deflation cycle is based on the electrocardiogram and arterial blood pressure waveform.
- When heart failure is severe, the IABP cannot provide adequate circulatory support because it cannot replace cardiac function. The treatment of severe heart failure requires the use of cardiac-bypass blood pumps. These devices are more invasive than the IABP and employ direct cannulation of the ventricle or atrium. Implantation and removal of the cardiac cannulas may further injure the heart and be associated with bleeding complications. It is estimated that nearly 100,000 patients worldwide underwent short-term mechanical circulatory support during 2000.
- Because of the limitations of aortic bypass pumps, intra-aortic balloon pumps, and the complications associated with cardiac bypass pumps, there is a need for an improved short-term heart-assist device.
- The present invention relates generally to methods and devices for mechanically assisting the failing heart. More specifically, it relates to balloon catheters and bypass pumps.
- The related art can be reviewed by the following patents. The full disclosures of the following patents are incorporated herein by this reference:
- The following patents disclose intra-aortic balloon pumps. The full disclosures of these patents are all incorporated herein by this reference:
6,290,641 Intra-aortic balloon pump having improved automated electrocardiogram based intra-aortic balloon deflation timing 6,245,008 Fast response intra-aortic balloon pump 6,241,706 Fast response intra-aortic balloon pump 6,238,382 Intra-aortic balloon catheter having a tapered Y-fitting 6,210,319 Intra-aortic balloon pump condensation prevention system 6,191,111 Method and device for enhancing of biobypass by increasing the coronary blood flow 5,817,001 Method and apparatus for driving an intra-aortic balloon pump - The following patents disclose intra-aortic balloons. The full disclosures of these patents are all incorporated herein by this reference:
6,213,975 Intra-aortic balloon catheter having an ultra-thin stretch blow molded balloon membrane 6,149,578 Piston-action intra-aortic coronary assist device 6,024,693 Intra-aortic balloon catheter 5,935,501 Method for making a packaging sheath for intra-aortic balloon catheters 5,928,132 Closed chest intra-aortic balloon based ventricular assist device 5,913,814 Method and apparatus for deflation of an intra-aortic balloon 5,865,721 Intra-aortic balloon catheters 5,817,001 Method and apparatus for driving an intra-aortic balloon pump 5,772,631 Procedure for alleviating arterial obstruction 5,759,175 Intra-aortic balloon catheter 5,718,861 Method of forming intra-aortic balloon catheters 5,697,906 Intra-aortic balloon catheter 5,683,347 Balloon catheter 5,618,270 Transthoracic aortic sleeve 5,599,329 Multi purpose perfusion cannula 5,524,757 Packaging sheaths for intra-aortic balloon catheters 5,460,607 Balloon catheter 5,456,665 Intra-aortic balloon catheter RE34,993 Method of inserting a lab device into the body 5,413,549 Devices and methods for efficient intra-aortic balloon pumping 5,330,451 Multi purpose perfusion cannula 5,230,692 Intra-aortic balloon pump 5,158,529 Pumping device for operating an intra-aortic balloon 5,120,299 Intra-aortic balloon assembly with hemostasis device 4,994,018 Intra-aortic balloon assembly 4,901,707 Prepackaged intra-aortic balloon assembly with holder, and method of using same 4,897,077 Method of inserting an IAB device into the body 4,827,906 Apparatus and method for activating a pump in response to optical signals from a pacemaker 4,809,681 Electrocardiographic measurement method for controlling an intra-aortic balloon pump 4,804,358 Coronary perfusion pump 4,733,652 Intra-aortic balloon 4,697,573 Percutaneous intra-aortic balloon and method for using same 4,644,936 Percutaneous intra-aortic balloon and method for using same 4,576,142 Percutaneous intra-aortic balloon and method for using same 4,552,127 Percutaneous intra-aortic balloon having an EKG electrode and a twisting stylet for coupling the EKG electrode to monitoring and/or pacing instrumentation external to the body 4,531,512 Wrapping system for intra-aortic balloon utilizing a wrapping envelope 4,522,195 Apparatus for left heart assist 4,522,194 Method and an apparatus for intra-aortic balloon monitoring and leak detection 4,515,587 IAB having apparatus for assuring proper balloon inflation and deflation 4,473,067 Introducer assembly for intra-aortic balloons and the like incorporating a sliding, blood-tight seal 4,467,790 Percutaneous balloon 4,444,186 Envelope wrapping system for intra-aortic balloon 4,422,447 Percutaneous balloon 4,407,271 Apparatus for left heart assist 4,402,307 Balloon catheter with rotatable energy storing support member 4,362,150 Percutaneous intra-aortic balloon apparatus 4,346,698 Balloon catheter with rotatable support 4,327,709 Apparatus and method for the percutaneous introduction of intra-aortic balloons into the human body 4,311,133 Intra-aortic balloon 4,287,892 Cannula for intra-aortic balloon devices and the like 4,276,874 Elongatable balloon catheter 4,261,339 Balloon catheter with rotatable support 4,122,858 Adapter for intra-aortic balloons and the like 4,080,958 Apparatus for aiding and improving the blood flow in patients 3,985,123 Method and means for monitoring cardiac output - Aortic occlusion balloons are known in the prior art. Such aortic balloons are non co-pulsating with the heartbeat and are not employed with an aortic bypass pump. The following patents disclose aortic occlusion balloons. The full disclosures of these patents are all incorporated herein by this reference:
6,254,563 Perfusion shunt apparatus and method 6,248,086 Method for cannulating a patient's aortic arch and occluding the patients ascending aortic arch 5,413,558 Selective aortic perfusion system for use during CPR 5,216,032 Selective aortic arch perfusion using perfluorochemical and alpha-adrenergic agonist to treat cardiac arrest 5,195,942 Cardiac arrest treatment 4,697,574 Pump for assistance in circulation 4,531,936 Device and method for the selective delivery of drugs to the myocardium - The following patents disclose cardiac bypass pumps. The full disclosures of these patents are all incorporated herein by this reference:
6,238,334 Method and apparatus for assisting a heart to pump blood 6,149,683 Power system for an implantable heart pump 6,099,460 Electromagnetic head-assist technique and apparatus 6,015,434 Artificial heart pump 5,588,812 Implantable electric axial-flow blood pump 5,443,503 Artificial heart pump 5,344,443 Heart pump - Aortic bypass pumps are known in the prior art. Aortic bypass pumps are not employed with a co-pulsating aortic occlusion balloon for heart assistance. The following patents disclose aortic bypass pumps. The full disclosures of these patents are all incorporated herein by this reference:
6,299,575 Implantable heart assist system 6,200,260 Implantable heart assist system 5,749,855 Catheter pump 4,968,293 Circulatory assist device - A preferred embodiment of the present invention provides a method and a system to temporarily assist the failing heart. The temporary heart-assist system comprises an occluding device positionable in the patient's descending aorta. The occluding device may or may not include a pressure sensor that electrically couples to an extra-corporeal controller. The occluding device itself also couples pneumatically to the extra-corporeal controller. The pump inlet of an extra-corporeal pump is connectable via a cannula to a patient's supra-diaphragmatic artery. The pump outlet of the extra-corporeal pump is connectable via a cannula to a patient's infra-diaphragmatic artery.
- In the method of the present invention, a doctor inserts into the patient the occluding device via a peripheral artery into the descending aorta, and positions the occluding device near the level of the patient's diaphragm. The occluding device catheter, coupled to the extra-corporeal controller, inflates and deflates the occluding device. The electrocardiogram ECG and proximal aortic blood pressure, measured in the upper arterial compartment via a lumen in the occluding device catheter, serve as inputs to cycle the occluding device synchronously with the heartbeat. The step of inflating occurs just prior to the start of cardiac systole co-pulsation and ventricular ejection. The extra-corporeal pump continuously or cyclically pumps blood from a supra-diaphragmatic-artery to a infra-diaphragmatic artery. The pumping flow rate varies in response to the end-systolic pressure measured in the upper arterial compartment of the patient's body. The step of deflating the aortic balloon occurs at the start of cardiac diastole and aortic valve closure. Deflating the balloon stabilizes the perfusion pressure between the upper and lower arterial compartments.
- In another feature of the present invention, the method of the present invention pumps blood from the patient's upper to the patient's lower arterial compartments.
- The present invention is designed to temporarily assist the failing human heart for a period of several hours to several days. The objectives of the heart-assist system of the present invention are to augment cardiac output and enhance systemic perfusion, reduce the workload and oxygen requirements of the acutely failing heart and allow for its recovery, allow for optimization of concomitant drug therapy, require minimal surgical intervention for insertion and removal, and reduce additional trauma to the failing heart by eliminating a need for direct cannulation of the left atrium or left ventricle. An additional feature of this technology is enhancement of diastolic perfusion by elevation of pressure throughout the diastolic interval and, unlike a commercially available balloon pump, enhancement of perfusion to all organs.
- The present invention allows for treatment of the failing heart in a minimally invasive manner with augmentation of left ventricular stoke volume cardiac output and simultaneous reduction in left ventricular workload and oxygen requirements of the heart.
- An important feature of the invention is that it rapidly inflates a small-volume balloon, partially occluding the aorta just prior to the start of cardiac systole and ventricular ejection. In another feature of the invention, it regulates aorta-aorta bypass blood pump flow to obtain a specific end-systolic aortic pressure measured in the upper arterial compartment. In another feature of the invention, decreasing end-systolic aortic pressure results in an increased ventricular stroke volume based on the ventricular pressure-volume-contractility relationship. Decreased systolic pressure also reduces the workload on the failing heart. Increased bypass pump blood flow elevates perfusion pressure in the lower arterial compartment. In another feature of the invention, during ventricular diastole, the system rapidly deflates an aortic balloon at end-systole. Deflating the aortic balloon stabilizes the perfusion pressure between the upper and lower arterial compartments.
- FIG. 1 depicts an overview of the temporary heart-assist system, illustrating the intra-aortic balloon, aortic-aortic external bypass pump, and external controller, as installed on a patient.
- FIG. 2 is a detailed view of the intra-aortic balloon and associated catheter, illustrating some of their features.
- FIG. 3A is a schematic of the temporary heart-assist system, illustrating the intra-aortic balloon, aortic-aortic external bypass pump, and external controller, as installed on a patient.
- FIG. 3B is a schematic of a human heart, depicting part of an inlet catheter with the tip of the catheter positioned through the aortic valve into the left ventricle.
- FIG. 4 is a graph of the left ventricular-pressure-volume-contractility relationships for the normal heart, failing heart, and failing heart supported with the temporary heart-assist system according to the present invention.
- FIG. 5A is a graph showing the electrocardiogram and aortic blood pressures of the failing heart.
- FIG. 5B and FIG. 5C are graphs showing the electrocardiogram, aortic blood pressures, aortic balloon inflation/deflation timing, and bypass pump flow rate or motor speed with the temporary heart-assist system operating.
- FIG. 6A is a schematic of the external control unit illustrating manual controls, transducer inputs, monitor display, aortic balloon pneumatics, and bypass pump electronics.
- FIG. 6B is a schematic of the assist timing control panel, illustrating the method for setting the inflation and deflation timing of the aortic balloon.
- FIG. 6C is a schematic of the pressure assist control panel, illustrating the method for setting the degree of systolic pressure unloading of the heart.
- FIG. 6D is a detailed graph showing the control-logic loop for the heart assist system.
- In the drawings, like numerals designate like parts throughout the drawings. In FIG. 1, a temporary heart-
assist system 7 is illustrated in use with a human heart. The heart-assist system 7 includes an occluding device, or balloon, 8 in the patient's aorta, connected to acontroller 9, Which in turn connects to an extracorporeal aortic bypass blood pump 10.The occludingdevice 8 can be any device that can be remotely opened and closed, either partially or fully, but in the preferred embodiment is a balloon. U.S. Pat. Nos. 5,894,273 and 6,137,416 disclose a limited-use controller that does not control an intra-aortic valve, such as theballoon 8. Such a controller could be used to control the aorticbypass blood pump 10. The deflatedballoon 8 is mounted on the end of aflexible catheter 11. Theballoon 8 andcatheter 11 are inserted into the aorta via a peripheral artery, preferably at apoint 12 on the femoral artery. The catheter 11may be inserted percutaneously over a guide wire or surgically by direct exposure of the vessel. Theballoon 8 is positioned in the descending thoracic aorta at approximately the level of the diaphragm. More specifically, theballoon 8 is placed above the diaphragm, but below the subclavian artery. - Referring now to FIG. 2, the aortic blood pressure AoP is recorded with two pressure transducers, or
sensors 13 on theballoon 8. The pressure transducers 13 are conventional transducers, such as model number BP01, manufactured by the InvenSys Company located in Milpitas, Calif. Thecontroller 9 allows sustained flow to pump and reads upper and lower pressure for pump adjustments from theballoon sensors 13. Theballoon sensors 13 monitor pressure, and when pressure goes up then pump flow increases, and vice versa. The principle of theballoon 8 is to equalize pressure during systole, and to auto-regulate the flow rate of thepump 10, based on the pressure sensed by thepressure sensors 13 on either side of theballoon 8. Theballoon 8 inflates as the aortic valve opens and deflates upon closure. If timed properly, there should be no period in which the aortic valve is closed and theballoon 8 inflated. In an alternate embodiment, only onesensor 13 is used. - The
catheter 11 has duel lumens. Alarger lumen 14 is used to shuttle gas to and from theballoon 8 via openings orports 15 located on a catheter wall. Asmaller lumen 16 runs continuously through the body of thecatheter 11. Thesmaller lumen 16 is used for inserting thecatheter 11 over an aortic guide wire and as a pressure transmission tube for the continuous measurement of central aortic pressure AoP proximal to theballoon 8 during operation of the heart-assist system 10. Theballoon 8 andcatheter 11 are made of biocompatible polymeric materials. Theballoon 8 andcatheter 11 are flexible and nontraumatic to the aorta, but have a wall thickness and strength sufficient to withstand cyclic rapid balloon inflation and deflation. - The pressure transducers13 connect to the pressure
transmission tube lumen 16. Thelumen 16 couples to acable 18 that connects to thecontroller 9. Theballoon 8 is inflated and deflated by gas pressure, preferably using helium gas, supplied through apneumatic tube 20 attached to thelarge lumen 14. Thetube 20 connects to thecontroller 9. Theballoon 8 deflates when depressurized with gas, and inflates when pressurized with gas, thereby partially or fully occluding the aorta. To avoid stagnation of the blood and vessel trauma, theballoon 8 does not need to completely occlude the descending aorta; it may leave some space on either side. - Referring now to FIG. 3A, the
left ventricle 22 of the heart is shown in systole with ejection of blood (long arrow) through the openedaortic outflow valve 24 into the ascendingaorta 26. Aninlet cannula 38 for thepump 10 is inserted into the aorta at apoint 40 proximal to theballoon 8, using conventional surgical techniques. Thepoint 40 may be in the ascendingaorta 26, for patients who have an open chest, or may be in a branch vessel, preferably the subclavian artery, for patients whose chest is not open, or at any point between. - Referring now to FIG. 3B, in an alternate embodiment, the length of the
inlet cannula 38 extends with its tip positioned through theaortic valve 24 into theleft ventricle 22.Holes 39 along the length of theinlet cannula 38 in the aorta, combined with ahole 39 in the tip of thecannula 38, provide direct unloading of theleft ventricle 22, plus afterload reduction in the aorta. - The lumen of the
inlet cannula 38 is of sufficient size and capacity to allow flow rates (see arrow) up to 7 liters per minute, with minimal pressure drop and blood destruction hemolysis. U.S. Pat. No. 6,007,478 discloses a cannula having constant wall thickness with increasing distal flexibility. The full disclosure of this patent is incorporated herein by this reference. Theinlet cannula 38 is brought out of the patient and connected to thepump 10. Thepump 10 is a commercially available non-pulsatile blood pump. Artificial heart pumps can be classified into the diaphragm type, the tube type, the roller pressure type, and the radial flow type that operates by rotational motion. Typical of the radial flow type is the centrifugal type. The following U.S. Patents disclose centrifugal heart pumps:5,894,273 Centrifugal blood pump driver apparatus 6,015,434 Artificial heart pump 6,137,416 Method of controlling centrifugal pump 6,227,817 Magnetically-suspended centrifugal blood pump - The full disclosures of these patents are all incorporated herein by this reference. The
pump 10 may be any radial pump, but in the preferred embodiment thepump 10 is a centrifugal pump. Adrive motor 42 powers thepump 10 via amagnetic coupling 44 located between thedrive motor 42 and thepump 10. Thepump 10 has the capacity to pump up to 7 liters per minute of blood without increased hemolysis or thrombosis clot formation. Pump flow rate is continuously measured using aconventional flow transducer 45 connected to thecontroller 9. Thetransducer 45 may be of the ultrasonic or electromagnetic type, but in the preferred embodiment is an ultrasonic model, made by Transonic Systems, Inc., located in Ithaca, N.Y. Blood returns to the patient via anoutlet cannula 46 inserted in an infra-diaphragmatic artery at apoint 48 far from theballoon 8, using conventional surgical techniques. Preferably, thepoint 48 is in the femoral artery. The lumen of theoutlet cannula 46 is of sufficient size and capacity to allow flow rates up to 7 liters per minute, with minimal pressure drop and hemolysis. - An electrocardiogram (“ECG”) is recorded via
electrodes 50 placed on the skin of the patient. The electrodes couple tocables 52 that connect to thecontroller 9. - The
pump drive motor 42 couples to thecontroller 9 via acable 62. The purpose of thepump 10 is to pump blood from the upperarterial compartment 14 to the lower arterial compartment. During ventricular systole, and using. the ECG and aortic pressure-triggeredcontroller 9, the small-volume balloon 8 is rapidly inflated, partially occluding the aorta. In the preferred embodiment, the flow rate of thepump 10 is regulated to obtain a specific end-systolic AoP in the upper arterial compartment (aorta 26). However, in an alternate embodiment, the pump runs continuously at a set speed. A deceased end-systolic aortic pressure afterload results in an increase in cardiac output blood flow. Decreased afterload also reduces the workload and oxygen consumption of the failing heart. Increased systemic blood flow also elevates perfusion pressure in the lower arterial compartment. During ventricular diastole, theballoon 8 rapidly deflates, thereby increasing the perfusion pressure throughout thearterial compartment 26. The pump flow rate can also be slowed during diastole by coasting or braking themotor 42, thereby reducing the potential for blood trauma hemolysis. Decreasing pump flow may be obtained by coasting or braking the speed of the centrifugal pump motor. In an alternate embodiment, thepump 10 runs continuously at a set speed. - Referring now to FIG. 4, the y-axis shows ventricular pressure 0-120 mmHg, and the x-axis shows ventricular volume 0-210 ml. An example of the pressure-volume relationship is shown for the normal N heart. Starting at the ventricular end-diastolic volume EDV for the normal heart N, the loop moves in a counter-clockwise direction. First the ventricle contracts and generates pressure sufficient to open the aortic valve AVO. The ventricle ejects blood into the aorta and the ventricular volume decreases. The ventricular stoke volume for each cardiac cycle is calculated by the formula: stoke volume ml/beat=EDV−ESV. At end-systole the aortic valve closes and pressure decreases as the walls of the ventricle relax during diastole. Following opening of the mitral valve MVO the left ventricle fills from the left atrium, containing oxygenated blood from the lungs, and ventricular volume increases. Contractility strength of contraction of the normal ventricle may be defined by the slope of the end-systolic pressure ESP-volume ESV relationship shown as solid line CN. Thus, for a given EDV, cardiac stroke volume decreases with increasing ESP and ESV. Conversely, stroke volume increases with decreasing ESP and ESV for a given EDV and contractility slope. With acute heart failure, the pressure-volume loop F1 is shifted downward and to the right. For this heart failure example, the contractility slope shown as dashed line CF is reduced and the EDV is increased. Despite the increase in EDV and decrease in ESP, the cardiac stroke volume is reduced due to decreased contractility slope. Because of the decreased contractility slope, the ventricle is more sensitive to changes in the ESP. Otherwise stated, with heart failure small changes in ESP lead to larger changes in ESV compared to the normal ventricle.
- FIG. 4 also illustrates the effects of the embodiments of the present invention on the failing heart. With actuation of the
aortic balloon 8 and the aortic-aortic bypass pump 10, the left ventricle is pressure and volume unloaded. During ventricular systole, theaortic balloon 8 is inflated, occluding the aorta, and thebypass blood pump 10 transfers blood from the upper arterial compartment to the lower arterial compartment. Pump flow rate is controlled increased or decreased to result in a set ESP level. Compared to the unassisted condition loop F1, the reduced ESP during mechanical assistance results in a reduced ESV loop F2 despite an unchanged contractility slope dashed line CF. Thus, reducing ESP and ESV with the heart-assist system 7 will increase cardiac stroke volume systemic perfusion and may also decrease ventricular EDV. Pressure and volume unloading of the ventricle also decreases systolic ventricular wall tension a primary component of cardiac muscle oxygen consumption. - The
aortic balloon 8 and aortic bypass pump 10 (axial or centrifugal flow device) are synchronously operated using the ECG-triggered and pressure-feedback controller 9. During ventricular systole the small-volume balloon 8 is rapidly inflated, partially occluding the aorta. The flow rate of the aorticbypass blood pump 10 is regulated to obtain a specific end-systolic aortic pressure in the upper arterial compartment. A decreased end-systolic aortic pressure provided by the blood pump results in ventricular unloading and augmentation of systemic perfusion (stroke volume and cardiac output). Thepump 10 assumes the circulation to the lower half of the body and the weakened heart is responsible for the upper half of the body only. Decreased afterload also reduces the workload on the failing heart. The increased systemic blood flow elevates perfusion pressure in the lower half of the body. During ventricular diastole, the balloon is deflated and the pump-generated pressure and flow increases the perfusion pressure throughout the arterial tree. Compared to the prior art intra-aortic balloon pumps, the invention provides greater augmentation of systemic perfusion, improved direct ventricular unloading, and increased diastolic perfusion, and without direct cannulation of the left ventricle or atrium as required for cardiac bypass devices. - Because of aortic occlusion, the
pump 10 flows from high pressure to lower pressure and will actually assume about 60% of the work. It is important to note that thepump 10 makes diastole become active. Thepump 10 achieves systolic unloading by augmenting flow and increased blood flow during diastolic which reduces load to the heart. - FIG. 5A and 5b illustrate the functioning of the heart-
assist system 7. FIG. 5A shows the ECG and AoP for the heart failure condition with theassist system 7 off. The ECG is recorded from skin electrodes appropriately placed on the patient. The R-wave 75 of the ECG corresponds with the start of ventricular systole and is used as a control trigger. The AoP shows the pressure recorded in the proximal aorta solid line and distal aorta dashed line. With the assist system off and the aortic balloon deflated, the proximal and distal aortic pressures are essentially equal. The start ofsystole 78 corresponds with the EDP time. The end ofsystole 79 corresponds with the ESP time. The systolic period S is when left ventricular ejection into the aorta occurs. The diastolic period D is when the ventricle relaxes and coronary perfusion occurs. - Referring now to FIG. 5B and FIG. 5C, ,with the heart assist
system 7 on, the aortic balloon is activated in two stages: inflation during ventricular systole S and deflation during cardiac diastole D. As shown in FIG. 5B and FIG. 5C, the R-wave of the ECG is used to trigger balloon inflation. The start ofballoon inflation 90 is controlled to obtain a preset EDP level measured in the proximal aorta using thepressure transmission lumen 16 of theaortic catheter 11. During inflation theballoon 8 makes uniform and firm contact with the inside wall of the aorta. This has the effect of blocking the downstream flow of blood in the aorta during systole. Thus, a closed volume is created between the outflow valve of the ventricle and the expandedballoon 8. - At the time of systolic
S balloon inflation 90, the aortic bypass pump shunts blood from the upper arterial compartment proximal aorta to the lower arterial compartment distal aorta. The centrifugal blood pump flow rate and RPM are regulated by theexternal controller 9 to obtain a preset ESP level measured in the aorta proximal to the inflated balloon. Thereby, the proximal aortic pressure is decreased solid line 80 and the distal aortic pressure is increased dashedline 82 during systole S compared to the unassisted condition shown in FIG. 5A. At the end of systole start of diastole, the aortic balloon is rapidly deflated 92. Thus the aorta is opened between the upper and lower arterial compartments, and the two pressures equilibrate. The equilibration results in increased proximalsolid line 84 and distal dashedline 86 aortic pressures during diastole D compared to the unassisted condition illustrated in FIG. 5A. Therefore, the heart-assist system described in the present invention is capable of increasing cardiac stroke volume and systemic perfusion, reducing ventricular workload and oxygen consumption, and increasing perfusion pressure to the coronary arteries supplying the heart. Also shown in FIG. 5B and FIG. 5C, the flow rate and RPM of the centrifugal aortic-aortic bypass pump may be increased 94 at the time to correspond 95 withaortic balloon inflation 90. This provides for maximum pressure and volume unloading of the ventricle 80 and augmentation ofdistal perfusion pressure 82. Additionally, the flow rate and RPM of the centrifugal blood pump may be decreased 97 at the time to correspond 98 withaortic balloon deflation 92. The reduced flow rate may decrease the degree of pump-induced hemolysis. - FIG. 6A illustrates the components of the heart-assist
system control unit 9. Manual controls 100 are used to set the timing of balloon inflation and deflation, and to set the degree of pressure assist provided by the centrifugal blood pump. The control unit containspreamplifiers 102 withEKG 52,aortic pressure 18, and pumpflow 45 inputs. Control setting and transducer signals are passed through an A/D converter 104 with before being sent to theprocessor unit 106 and monitordisplay subsystem 108. Based on transducer signals and control settings, the processor unit controls and monitors thepneumatic subsystem 110 that provides gas pressure and vacuum to inflate and deflate the aortic balloon, respectively, via apneumatic drive line 20.Processor unit 106 contains a microprocessor such as a Motorola 68HC11, random access memory (RAM) and program memory (PROM) which contains software to control the system. The processor unit also controls and monitors themotor control subsystem 112, that sends power to the centrifugal blood pump drive motor via aelectronic cable 64. - FIG. 6B illustrates the
timing control panel 114, on the external control unit, that is used for setting aorticballoon AoB inflation 116 anddeflation 118 timing with respect to the R-wave of theelectrocardiogram 75 as a percentage of the R-R time interval. With the assist pump and balloon turned off, the aortic balloon inflation time is established by manually moving theslide control 120 that controls acursor line 122 simultaneously shown on themonitor display 108. The slide control is moved such that the cursor line corresponds with end-diastole ED and theED pressure 124 overlying the displayedaortic pressure waveform 126. Additionally, balloon deflation time is established by manually moving theslide control 128 that controls asecond cursor line 130 on the display monitor. The slide control is moved such that the cursor line corresponds with end-systole ES and theES pressure 132 for the aortic pressure waveform. In the event that heart rate changes by +10 beats per minute, the assist pump and balloon should be turned off and the inflation and deflation timing reestablished. - FIG. 6C illustrates the pressure assist
Pa control panel 140, on the external control unit, that is used for setting the degree of ventricular unloading provided by the aortic bypass pump. The degree of ventricular unloading is determined by the measured difference between the aortic enddiastolic pressure EDP 142 and the endsystolic pressure ESP 144. Acontrol knob 146 is manually set to establish the degree of pressure unloading which ranges from a negative 5 mmHg to a positive 5 mmHg. A control knob setting of 0 corresponds with the ESP=EDP. This setting provides a moderate level of ventricular unloading and heart assist. A setting of −5 corresponds with the ESP being 5 mmHg less than the corresponding EDP. This setting provides the maximum level of ventricular unloading and heart assist. A setting of +5 corresponds with the ESP being 5 mmHg more than the EDP. This setting provides the minimum level of ventricular unloading and is used for weaning from the heart assist system. The illustrated control method allows for beat-to-beat control of pump flow rate regardless of changes in the systemic vascular resistance and blood pressure. Amanual push button 148 must be depressed simultaneously with changing the control knob setting. This method is used to prevent inadvertent changes in the pressure assist setting. - FIG. 6D is a detailed flow diagram of the heart-assist
system control logic 150. Beat to beat control of the aortic occlusion balloon and aortic bypass pump is started with electrocardiogram R-wave detection 152. With R-wave detection the timing clock and monitor displays are reset and the preceding R-R interval time is measured 154. Based on the percentage ED and ES control setting 156 shown in FIG. 7, the ED and ES times in seconds is calculated 158 for the measuredR-R interval 154. Aortic balloon inflation IT anddeflation DT times 160 are calculated by subtracting a known electromechanical delay time for the pneumatic subsystem from the previously calculated ED andES times 158, respectively. At the calculated balloon inflation time IT following R-wave detection, atrigger signal 162 is sent to thepneumatic subsystem 110 to provide drive gas to the aortic balloon. At the calculated ED time, the ED pressure EDP is measured 164 from the aortic pressure input signal. Based on the pressure assist control setting shown in FIG. 8, the calculatedES pressure ESPc 168 is determined using the formula: ESPc=measuredEDP 164 minus the pressure assist Pa setting 146. At the calculated balloon deflation time DT following R-wave detection, atrigger signal 170 is sent to thepneumatic subsystem 110 to exhaust drive gas from the aortic balloon. At the calculated ES time, the ES pressure ESP is measured 172 from the aortic pressure input signal. - The calculated
pressure difference Pdif 174 is determined using the formula: Pdif=measuredESP 172 minus the calculatedESPc 168. The bypass pump speed RPM change is determined 176 based on the calculatedPdif 174. Positive Pdif values result in increasing pump speeds. Conversely, negative Pdif values result in decreasing pump speeds. A speedcontrol change signal 178 is sent to themotor control subsystem 112 which regulates centrifugal pump flow. Following the above steps, the control logic unit waits for the next R-wave detection 180. - Thus, the invention provides a method and apparatus for assisting the failing heart until such time that ventricular recovery and weaning from the assist system occurs. There are several advantages of this invention over prior intra-aortic balloon pump and ventricular assist devices. The invention is particularly useful in increasing cardiac output and decreasing ventricular loading without direct cannulation of the left atrium or left ventricle. The method includes controlled intermittent occlusion of the aorta synchronously with the cardiac cycle, accompanied by the pumping of blood from the proximal to the distal aorta at a rate sufficient to pressure and volume unload the failing left ventricle. Systolic ventricular unloading increases cardiac output and decreases myocardial oxygen demands. Augmented cardiac output levels also increase perfusion of the coronary arteries supplying oxygenated blood to the heart.
- Although the preferred embodiment of the present invention has been described above, it will be understood by those skilled in the art that numerous modifications from the present invention may be made without departing from the scope and meaning of the claims that follow.
Claims (23)
1. A method for temporarily assisting a heart of a patient, the patient wearing ECG sensors with attached electrodes, the method comprising the steps of:
a. inserting an occluding device, having a pressure sensor, into the patient's descending aorta;
b. positioning the occluding device near the level of the patient's diaphragm;
c. coupling the occluding device to an extra-corporeal controller; and
d. opening and closing the balloon in response to signals from the ECG electrodes.
2. The method of claim 1 , wherein the step of closing occurs just prior to the start of cardiac systole and ventricular ejection.
3. The method of claim 2 , further comprising the step of using an extra-corporeal pump to continuously pump blood from a patient's supra-diaphragmatic artery to an infra-diaphragmatic artery.
4. The method of claim 3 , wherein in the step of continuously pumping blood, the pumping flow rate varies in response to the end-systolic pressure measured in the upper arterial compartment of the patient's body.
5. The method of claim 4 , wherein the extra-corporeal controller a) causes the occluding device to intermittently occlude the aorta, synchronously with the patient's cardiac cycle, and b) causes the extra-corporeal pump to pump blood from the patient's proximal to the distal aorta at a rate sufficient to pressure and volume unload the patient's failing left ventricle.
6. The method of claim 5 , wherein the extra-corporeal controller decreases the flow rate and RPM of the extra-corporeal pump when it opens the occluding device.
7. The method of claim 6 ,. wherein an inlet cannula of the extra-corporeal pump is inserted through an aortic valve into the left ventricle, the inlet cannula having holes along a length of it positioned in the aorta, and a hole in a tip, which is positioned in the left ventricle, for providing direct unloading of the left ventricle, and after-load reduction in the aorta.
8. A method for temporarily assisting a heart of a patient, the patient wearing ECG sensors with attached electrodes, the method comprising the steps of:
a. inserting a balloon, having a balloon catheter and two pressure sensors, into the patient's descending aorta;
b. positioning the balloon near the level of the patient's diaphragm;
c. coupling the balloon catheter to an extra-corporeal controller;
d. inflating the balloon in response to signals from the ECG electrodes, and the two pressure sensors; and
e. deflating the balloon in response to signals from the ECG electrodes, and the two pressure sensors.
9. The method of claim 8 , wherein the step of inflating occurs just prior to the start of cardiac systole and ventricular ejection.
10. The method of claim 9 , further comprising the step of using an extra-corporeal pump to continuously pump blood from a patient's supra-diaphragmatic artery to an infra-diaphragmatic artery.
11. The method of claim 10 , wherein in the step of continuously pumping blood, the pumping flow rate varies in response to the end-systolic pressure measured in the upper arterial compartment of the patient's body.
12. The method of claim 11 , wherein the extra-corporeal controller a) causes the balloon to intermittently occlude the aorta, synchronously with the patient's cardiac cycle, and b) causes the extra-corporeal pump to pump blood from the patient's proximal to the distal aorta at a rate sufficient to pressure and volume unload the patient's failing left ventricle.
13. The method of claim 12 , wherein the extra-corporeal controller decreases the flow rate and RPM of the extra-corporeal pump when it deflates the balloon.
14. A method for temporarily assisting a heart of a patient, the patient wearing ECG sensors with attached electrodes, and the patient also having an intra-aortic occluding device having two pressure sensors, the method comprising the steps of:
a. opening and closing the intra-aortic occluding device by an extra-corporeal controller in response to signals from the ECG electrodes and the two pressure sensors; and
b. continuously pumping blood by an extra-corporeal pump from a patient's supra-diaphragmatic artery to an infra-diaphragmatic artery
15. The method of claim 14 , wherein the step of closing occurs just prior to the start of the patient's cardiac systole and ventricular ejection.
16. The method of claim 15 , wherein the pumping flow rate varies in response to the end-systolic pressure measured in the upper arterial compartment of the patient's body.
17. The method of claim 16 , wherein the extra-corporeal controller a) causes the occluding device to intermittently occlude the aorta, synchronously with the patient's cardiac cycle, and b) causes the extra-corporeal pump to pump blood from the patient's proximal to the distal aorta at a rate sufficient to pressure and volume unload the patient's failing left ventricle.
18. The method of claim 11 , wherein the extra-corporeal controller decreases the flow rate and RPM of the extra-corporeal pump when it opens the occluding device.
19. A method for temporarily assisting a heart of a patient, the patient wearing ECG sensors with attached electrodes, and the patient also having an intra-aortic balloon having two pressure sensors, the method comprising the steps of:
a. inflating the intra-aortic balloon by an extra-corporeal controller in response to signals from the ECG electrodes and the two pressure sensors;
b. deflating the intra-aortic balloon by an extra-corporeal controller in response to signals from the ECG electrodes and the two pressure sensors; and
c. continuously pumping blood by an extra-corporeal pump from a patient's supra-diaphragmatic artery to an infra-diaphragmatic artery.
20. The method of claim 19 , wherein the step of inflating occurs at the onset or during the patient's cardiac systole and ventricular ejection.
21. The method of claim 20 , wherein the pumping flow rate varies in response to the end-systolic pressure measured in the upper arterial compartment of the patient's body.
22. The method of claim 21 , wherein the extra-corporeal controller a) causes the balloon to intermittently occlude the aorta, synchronously with the patient's cardiac cycle, and b) causes the extra-corporeal pump to pump blood from the patient's proximal to the distal aorta at a rate sufficient to pressure and volume unload the patient's failing left ventricle.
23. The method of claim 22 , wherein the extra-corporeal controller decreases the flow rate and RPM of the extra-corporeal pump when it deflates the balloon.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/603,669 US20040015043A1 (en) | 2002-03-26 | 2003-06-25 | Temporary heart assist system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/106,744 US6669624B2 (en) | 2002-03-26 | 2002-03-26 | Temporary heart-assist system |
US10/603,669 US20040015043A1 (en) | 2002-03-26 | 2003-06-25 | Temporary heart assist system |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/106,744 Division US6669624B2 (en) | 2002-03-26 | 2002-03-26 | Temporary heart-assist system |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040015043A1 true US20040015043A1 (en) | 2004-01-22 |
Family
ID=28673553
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/106,744 Expired - Lifetime US6669624B2 (en) | 2002-03-26 | 2002-03-26 | Temporary heart-assist system |
US10/603,669 Abandoned US20040015043A1 (en) | 2002-03-26 | 2003-06-25 | Temporary heart assist system |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/106,744 Expired - Lifetime US6669624B2 (en) | 2002-03-26 | 2002-03-26 | Temporary heart-assist system |
Country Status (3)
Country | Link |
---|---|
US (2) | US6669624B2 (en) |
AU (1) | AU2003213182A1 (en) |
WO (1) | WO2003082379A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040152945A1 (en) * | 2003-01-31 | 2004-08-05 | Adrian Kantrowitz | Stable aortic blood pump implant |
WO2005110512A1 (en) * | 2004-05-11 | 2005-11-24 | Ppa Technologies Ag | Device for epicardial support and/or resumption of cardiac activity |
US9694122B2 (en) * | 2003-01-31 | 2017-07-04 | L-Vad Technology, Inc. | Rigid body aortic blood pump implant |
US20210187274A1 (en) * | 2017-10-20 | 2021-06-24 | Pulsecath B.V. | Catheter pump system and method of controlling a catheter pump drive |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL154531A (en) * | 2003-02-19 | 2006-04-10 | Yair Tal | Device and method for regulating blood flow |
JP4192040B2 (en) * | 2003-06-11 | 2008-12-03 | 泉工医科工業株式会社 | Balloon pump drive device |
US7320599B2 (en) * | 2003-10-02 | 2008-01-22 | Gary Jay Morris | Blood pressure simulation apparatus with tactile interface |
US7513864B2 (en) * | 2004-07-09 | 2009-04-07 | Kantrowitz Allen B | Synchronization system between aortic valve and cardiac assist device |
ITBO20050143A1 (en) * | 2005-03-11 | 2006-09-12 | Running Heart Libera Associazione | DEVICE FOR CONTROL OF AORTA PRESSURE |
DE102005060197A1 (en) * | 2005-12-14 | 2007-06-21 | Rheinisch-Westfälisch Technische Hochschule Aachen | catheter device |
US20080249456A1 (en) * | 2007-03-27 | 2008-10-09 | Syuuji Inamori | Pulsation-type auxiliary circulation system, pulsatile flow generation control device, and pulsatile flow generation control method |
JP5266464B2 (en) * | 2007-05-10 | 2013-08-21 | ライニッシュ−ヴェストフェリッシェ・テクニッシェ・ホッホシューレ・アーヘン | Cardiac function change evaluation device |
US8439859B2 (en) * | 2007-10-08 | 2013-05-14 | Ais Gmbh Aachen Innovative Solutions | Catheter device |
US8457738B2 (en) | 2008-06-19 | 2013-06-04 | Cardiac Pacemakers, Inc. | Pacing catheter for access to multiple vessels |
US20090318943A1 (en) * | 2008-06-19 | 2009-12-24 | Tracee Eidenschink | Vascular intervention catheters with pacing electrodes |
US9037235B2 (en) * | 2008-06-19 | 2015-05-19 | Cardiac Pacemakers, Inc. | Pacing catheter with expandable distal end |
US20090318749A1 (en) * | 2008-06-19 | 2009-12-24 | Craig Stolen | Method and apparatus for pacing and intermittent ischemia |
US8639357B2 (en) | 2008-06-19 | 2014-01-28 | Cardiac Pacemakers, Inc. | Pacing catheter with stent electrode |
US20100222635A1 (en) * | 2009-02-27 | 2010-09-02 | Thoratec Corporation | Maximizing blood pump flow while avoiding left ventricle collapse |
US20100222633A1 (en) * | 2009-02-27 | 2010-09-02 | Victor Poirier | Blood pump system with controlled weaning |
US20100222878A1 (en) * | 2009-02-27 | 2010-09-02 | Thoratec Corporation | Blood pump system with arterial pressure monitoring |
US8449444B2 (en) * | 2009-02-27 | 2013-05-28 | Thoratec Corporation | Blood flow meter |
US8562507B2 (en) * | 2009-02-27 | 2013-10-22 | Thoratec Corporation | Prevention of aortic valve fusion |
US8864644B2 (en) | 2010-01-19 | 2014-10-21 | Heartware, Inc. | Physiologically responsive VAD |
US11337707B2 (en) | 2010-05-25 | 2022-05-24 | Miracor Medical Sa | Treating heart tissue |
AU2011305243A1 (en) | 2010-09-24 | 2013-04-04 | Thoratec Corporation | Control of circulatory assist systems |
EP3020426B1 (en) | 2010-09-24 | 2017-12-27 | Tc1 Llc | Generating artificial pulse |
US11621583B2 (en) | 2012-05-21 | 2023-04-04 | University Of Washington | Distributed control adaptive wireless power transfer system |
US8827889B2 (en) | 2012-05-21 | 2014-09-09 | University Of Washington Through Its Center For Commercialization | Method and system for powering implantable devices |
US9789236B2 (en) | 2013-03-14 | 2017-10-17 | Yale University | Implantable heart pump controller |
US9919088B2 (en) | 2013-03-14 | 2018-03-20 | Yale University | Implantable heart pump controller |
WO2015160991A1 (en) | 2014-04-15 | 2015-10-22 | Thoratec Corporation | Methods and systems for controlling a blood pump |
EP2962710A1 (en) * | 2014-07-03 | 2016-01-06 | Berlin Heart GmbH | Method and heart support system for determining an outlet pressure |
EP3352809B1 (en) | 2015-09-25 | 2019-08-07 | Heartware, Inc. | Blood pump for ischemia detection and treatment |
US10117982B2 (en) * | 2016-04-15 | 2018-11-06 | Guy P. Curtis And Frances L. Curtis Trust | System and method for improving a heart muscle response |
EP3515526A1 (en) * | 2016-09-23 | 2019-07-31 | Heartware, Inc. | Field-oriented control for control of blood pump motor |
EP3634528B1 (en) | 2017-06-07 | 2023-06-07 | Shifamed Holdings, LLC | Intravascular fluid movement devices, systems, and methods of use |
CN110913923B (en) | 2017-06-09 | 2022-11-18 | 阿比奥梅德公司 | Determination of cardiac parameters for regulating blood pump support |
CN107158549A (en) * | 2017-06-29 | 2017-09-15 | 吴强 | For regulating and controlling left ventricle capacity to improve the servicing unit of Cardial pump function |
US11351355B2 (en) * | 2017-10-19 | 2022-06-07 | Datascope Corporation | Devices for pumping blood, related systems, and related methods |
CN111556763B (en) | 2017-11-13 | 2023-09-01 | 施菲姆德控股有限责任公司 | Intravascular fluid movement device and system |
DE102018201030A1 (en) | 2018-01-24 | 2019-07-25 | Kardion Gmbh | Magnetic coupling element with magnetic bearing function |
JP7410034B2 (en) | 2018-02-01 | 2024-01-09 | シファメド・ホールディングス・エルエルシー | Intravascular blood pump and methods of use and manufacture |
US11690997B2 (en) | 2018-04-06 | 2023-07-04 | Puzzle Medical Devices Inc. | Mammalian body conduit intralumenal device and lumen wall anchor assembly, components thereof and methods of implantation and explanation thereof |
DE102018211327A1 (en) | 2018-07-10 | 2020-01-16 | Kardion Gmbh | Impeller for an implantable vascular support system |
US10960118B2 (en) * | 2018-07-31 | 2021-03-30 | Abiomed, Inc. | Systems and methods for controlling a heart pump to minimize myocardial oxygen consumption |
CN109289096A (en) * | 2018-10-16 | 2019-02-01 | 张义雄 | A kind of interim implantable cardiac pump blood device |
WO2020163504A1 (en) * | 2019-02-06 | 2020-08-13 | inQB8 Medical Technologies, LLC | Intra-cardiac left atrial and dual support systems |
CN110448748B (en) * | 2019-07-11 | 2021-12-17 | 安徽通灵仿生科技有限公司 | Intra-aortic balloon counterpulsation system and control method thereof |
WO2021016372A1 (en) | 2019-07-22 | 2021-01-28 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
EP4034192A4 (en) | 2019-09-25 | 2023-11-29 | Shifamed Holdings, LLC | Intravascular blood pump systems and methods of use and control thereof |
CN111298225A (en) * | 2019-12-02 | 2020-06-19 | 李勇 | Balloon heart counterpulsation device comprising electromagnet |
WO2021117021A1 (en) * | 2019-12-12 | 2021-06-17 | Puzzle Medical Devices Inc. | System and method for assisting flow of a fluid in a vascular system of a mammalian body |
DE102020102474A1 (en) | 2020-01-31 | 2021-08-05 | Kardion Gmbh | Pump for conveying a fluid and method for manufacturing a pump |
CN111330103A (en) * | 2020-03-10 | 2020-06-26 | 中国医科大学附属第一医院 | Intelligent hemodynamic auxiliary instrument |
CN114377288A (en) * | 2021-12-21 | 2022-04-22 | 中国医学科学院阜外医院 | Method for synchronously jumping along with heart for ventricular external pressing type heart auxiliary device |
CN114259646A (en) * | 2022-01-11 | 2022-04-01 | 丰凯利医疗器械(上海)有限公司 | Blood circulation auxiliary device and control system |
CN116687495B (en) * | 2023-07-24 | 2023-11-03 | 上海宏普医疗器械有限公司 | Implanted saccule |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4327709A (en) | 1978-03-06 | 1982-05-04 | Datascope Corp. | Apparatus and method for the percutaneous introduction of intra-aortic balloons into the human body |
US4261339A (en) | 1978-03-06 | 1981-04-14 | Datascope Corp. | Balloon catheter with rotatable support |
US4311133A (en) | 1980-03-10 | 1982-01-19 | Thoratec Laboratories Corporation | Intra-aortic balloon |
IT1131170B (en) | 1980-05-12 | 1986-06-18 | Consiglio Nazionale Ricerche | HEART PUMP FOR THE EXTRACORPOREAL BLOOD CIRCULATION WITH SLOWING OF THE BLOOD FLOW DURING THE EXTRACORPOREA CIRCULATION |
US4362150A (en) | 1980-09-10 | 1982-12-07 | Kontron Cardiovascular Inc. | Percutaneous intra-aortic balloon apparatus |
US4402307A (en) | 1980-10-31 | 1983-09-06 | Datascope Corp. | Balloon catheter with rotatable energy storing support member |
US4531936A (en) | 1981-01-29 | 1985-07-30 | Gordon Robert T | Device and method for the selective delivery of drugs to the myocardium |
US4467790A (en) | 1981-04-13 | 1984-08-28 | Peter Schiff | Percutaneous balloon |
US4444186A (en) | 1981-06-15 | 1984-04-24 | Datascope Corporation | Envelope wrapping system for intra-aortic balloon |
US4531512A (en) | 1981-06-15 | 1985-07-30 | Datascope Corporation | Wrapping system for intra-aortic balloon utilizing a wrapping envelope |
US4473067A (en) | 1982-04-28 | 1984-09-25 | Peter Schiff | Introducer assembly for intra-aortic balloons and the like incorporating a sliding, blood-tight seal |
US4901707A (en) | 1982-11-19 | 1990-02-20 | Iabp Corporation | Prepackaged intra-aortic balloon assembly with holder, and method of using same |
US4576142A (en) | 1982-11-19 | 1986-03-18 | Peter Schiff | Percutaneous intra-aortic balloon and method for using same |
US4644936A (en) | 1982-11-19 | 1987-02-24 | Iabp | Percutaneous intra-aortic balloon and method for using same |
US4522194A (en) | 1983-02-18 | 1985-06-11 | Baylor College Of Medicine | Method and an apparatus for intra-aortic balloon monitoring and leak detection |
US4552127A (en) | 1983-04-01 | 1985-11-12 | Peter Schiff | Percutaneous intra-aortic balloon having an EKG electrode and a twisting stylet for coupling the EKG electrode to monitoring and/or pacing instrumentation external to the body |
US4524466A (en) | 1983-11-30 | 1985-06-25 | Southwest Research Institute | Continuous rotation reversible pitch axial thrust heart pump |
FR2577424B1 (en) | 1985-02-20 | 1989-04-28 | Gilles Karcher | CORONARY PERFUSION PUMP |
FR2577423B1 (en) | 1985-02-20 | 1989-05-05 | Gilles Karcher | CIRCULATORY AND CORONARY ASSISTANCE PUMP WITH INTRA-AORTIC BALLOONS |
US4733652A (en) | 1985-12-31 | 1988-03-29 | Aisin Seiki Kabushiki Kaisha | Intra-aortic balloon |
US4809681A (en) * | 1986-03-28 | 1989-03-07 | Aisin Seiki Kabushiki Kaisha | Electrocardiographic measurement method for controlling an intra-aortic balloon pump |
US4822357A (en) | 1987-04-29 | 1989-04-18 | Articor Limited | Auxiliary artificial heart |
US4897077A (en) | 1987-05-22 | 1990-01-30 | Kontron Inc. | Method of inserting an IAB device into the body |
US4968293A (en) | 1989-03-20 | 1990-11-06 | Medtronic, Inc. | Circulatory assist device |
US4994018A (en) | 1989-05-31 | 1991-02-19 | Datascope Corporation | Intra-aortic balloon assembly |
US5571169A (en) | 1993-06-07 | 1996-11-05 | Endovascular Instruments, Inc. | Anti-stenotic method and product for occluded and partially occluded arteries |
JP2902040B2 (en) | 1990-03-29 | 1999-06-07 | アイシン精機株式会社 | Drive device of balloon pump with arterial pressure sensor |
JPH0460245U (en) | 1990-09-30 | 1992-05-22 | ||
US5263979A (en) | 1991-03-19 | 1993-11-23 | Kou Imachi | Artificial heart |
US5195942A (en) | 1991-08-12 | 1993-03-23 | Institute Of Critical Care Medicine | Cardiac arrest treatment |
US5413558A (en) | 1991-09-09 | 1995-05-09 | New York University | Selective aortic perfusion system for use during CPR |
US5344443A (en) | 1992-09-17 | 1994-09-06 | Rem Technologies, Inc. | Heart pump |
US5460607A (en) | 1992-09-30 | 1995-10-24 | Nippon Zeon Co., Ltd. | Balloon catheter |
US5330451A (en) | 1992-12-17 | 1994-07-19 | Shelhigh, Inc. | Multi purpose perfusion cannula |
JP2569419B2 (en) | 1993-02-18 | 1997-01-08 | 工業技術院長 | Artificial heart pump |
ES2157977T3 (en) | 1993-07-23 | 2001-09-01 | Cook Inc | FLEXIBLE PROBE THAT HAS A CONFORMED CONFIGURATION FROM A MATERIAL SHEET. |
US5718861A (en) | 1993-12-20 | 1998-02-17 | C. R. Bard, Incorporated | Method of forming intra-aortic balloon catheters |
US5456665C1 (en) | 1994-03-04 | 2001-05-22 | Arrow Internat Invest Corp | Intra-aortic balloon catheter |
US5524757A (en) | 1994-03-18 | 1996-06-11 | St. Jude Medical, Inc. | Packaging sheaths for intra-aortic balloon catheters |
US5478309A (en) | 1994-05-27 | 1995-12-26 | William P. Sweezer, Jr. | Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery |
US5588812A (en) | 1995-04-19 | 1996-12-31 | Nimbus, Inc. | Implantable electric axial-flow blood pump |
US5772631A (en) | 1995-04-28 | 1998-06-30 | Lepor; Norman E. | Procedure for alleviating arterial obstruction |
US5618270A (en) | 1995-05-26 | 1997-04-08 | Orejola; Wilmo C. | Transthoracic aortic sleeve |
DE69631430T2 (en) | 1995-11-13 | 2004-12-02 | Boston Scientific Corp., Natick | Intra-aortic balloon catheter |
JP2807786B2 (en) | 1996-07-26 | 1998-10-08 | 工業技術院長 | Artificial heart pump |
WO1998011847A1 (en) | 1996-09-20 | 1998-03-26 | Houser Russell A | Radially expanding prostheses and systems for their deployment |
US5817001A (en) | 1997-05-27 | 1998-10-06 | Datascope Investment Corp. | Method and apparatus for driving an intra-aortic balloon pump |
US5913814A (en) | 1997-08-26 | 1999-06-22 | Belmont Instrument Corporation | Method and apparatus for deflation of an intra-aortic balloon |
UA56262C2 (en) | 1997-10-09 | 2003-05-15 | Орквіс Медікел Корпорейшн | Extracardiac pumping system for supplementing blood circulation |
WO1999022784A1 (en) | 1997-11-03 | 1999-05-14 | Cardio Technologies, Inc. | Method and apparatus for assisting a heart to pump blood |
US6254563B1 (en) | 1997-12-15 | 2001-07-03 | Cardeon Corporation | Perfusion shunt apparatus and method |
US5928132A (en) | 1998-03-31 | 1999-07-27 | Datascope Investment Corp. | Closed chest intra-aortic balloon based ventricular assist device |
US6099460A (en) | 1998-04-28 | 2000-08-08 | Denker; Stephen | Electromagnetic heart assist technique and apparatus |
US6149683A (en) | 1998-10-05 | 2000-11-21 | Kriton Medical, Inc. | Power system for an implantable heart pump |
US6024693A (en) | 1998-10-16 | 2000-02-15 | Datascope Investment Corp. | Intra-aortic balloon catheter |
WO2000027461A1 (en) | 1998-11-09 | 2000-05-18 | Datascope Investment Corp. | Intra-aortic balloon catheter having an ultra-thin stretch blow molded balloon membrane |
US6149578A (en) | 1999-02-04 | 2000-11-21 | My-Tech, Inc. | Piston-action intra-aortic coronary assist device |
US6191111B1 (en) | 1999-02-17 | 2001-02-20 | Datascope Investment Corp. | Method and device for enhancing of biobypass by increasing the coronary blood flow |
US6210319B1 (en) | 1999-04-21 | 2001-04-03 | Datascope Investment Corp. | Intra-aortic balloon pump condensation prevention system |
US6290641B1 (en) | 1999-05-20 | 2001-09-18 | Datascope Investment Corp. | Intra-aortic balloon pump having improved automated electrocardiogram based intra-aortic balloon deflation timing |
US6241706B1 (en) | 1999-07-16 | 2001-06-05 | Datascope Investment Corporation | Fast response intra-aortic balloon pump |
US6238382B1 (en) | 1999-08-19 | 2001-05-29 | Datascope Investment Corp. | Intra-aortic balloon catheter having a tapered Y-fitting |
-
2002
- 2002-03-26 US US10/106,744 patent/US6669624B2/en not_active Expired - Lifetime
-
2003
- 2003-02-21 WO PCT/US2003/005259 patent/WO2003082379A1/en not_active Application Discontinuation
- 2003-02-21 AU AU2003213182A patent/AU2003213182A1/en not_active Abandoned
- 2003-06-25 US US10/603,669 patent/US20040015043A1/en not_active Abandoned
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040152945A1 (en) * | 2003-01-31 | 2004-08-05 | Adrian Kantrowitz | Stable aortic blood pump implant |
US8540618B2 (en) | 2003-01-31 | 2013-09-24 | L-Vad Technology, Inc. | Stable aortic blood pump implant |
US9433715B2 (en) | 2003-01-31 | 2016-09-06 | L-Vad Technology, Inc. | Stable aortic blood pump implant |
US9694122B2 (en) * | 2003-01-31 | 2017-07-04 | L-Vad Technology, Inc. | Rigid body aortic blood pump implant |
WO2005110512A1 (en) * | 2004-05-11 | 2005-11-24 | Ppa Technologies Ag | Device for epicardial support and/or resumption of cardiac activity |
US20070225545A1 (en) * | 2004-05-11 | 2007-09-27 | Ppa Technologies Ag | Device for the Epicardial Support and/or Resumption of Cardiac Activity |
US7691047B2 (en) | 2004-05-11 | 2010-04-06 | Ppa Technologies Ag | Device for the epicardial support and/or resumption of cardiac activity |
US20210187274A1 (en) * | 2017-10-20 | 2021-06-24 | Pulsecath B.V. | Catheter pump system and method of controlling a catheter pump drive |
US11925794B2 (en) * | 2017-10-20 | 2024-03-12 | Pulsecath B.V. | Catheter pump system and method of controlling a catheter pump drive |
Also Published As
Publication number | Publication date |
---|---|
US20030191357A1 (en) | 2003-10-09 |
WO2003082379A1 (en) | 2003-10-09 |
AU2003213182A1 (en) | 2003-10-13 |
US6669624B2 (en) | 2003-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6669624B2 (en) | Temporary heart-assist system | |
US11285311B2 (en) | Ventricular assist device control | |
US6179793B1 (en) | Cardiac assist method using an inflatable vest | |
US7229402B2 (en) | Minimally invasive ventricular assist technology and method | |
US4195623A (en) | Parallel aorta balloon pump and method of using same | |
US6428464B1 (en) | Implantable heart assist system | |
US4902272A (en) | Intra-arterial cardiac support system | |
US4014317A (en) | Multipurpose cardiocirculatory assist cannula and methods of use thereof | |
US4861330A (en) | Cardiac assist device and method | |
US7614998B2 (en) | Fully-implantable cardiac recovery system | |
US20070208210A1 (en) | Method and apparatus to unload a failing heart | |
US20030176760A1 (en) | Physiologically compatible cardiac assist device and method | |
WO1999051285A1 (en) | Auxiliary mechanical heart promoting the restoration of heart function | |
WO2023134639A1 (en) | Blood circulation assisting device and control system | |
US20220313889A1 (en) | Control for Non-Occlusive Blood Pumps | |
JP2021500196A (en) | How to control the catheter pump system and catheter pump drive | |
US20190344055A1 (en) | Intra-aortic dual balloon pump catheter device | |
CN111481763A (en) | Pulse type artificial lung extracorporeal circulation manager | |
JP2817957B2 (en) | Intra-aortic balloon pumping catheter | |
US20240066274A1 (en) | Intra-aortic dual balloon driving pump catheter device | |
SALABAT et al. | Counterpulsation Circulatory 17 Assist Devices | |
Sunavala | Mechanical Circulatory Supports | |
Koenig et al. | Hemodynamic and left ventricular pressure-volume responses to counterpulsation in mock circulation and acute large animal models | |
Ramm et al. | Cardiac 13 | |
JPH03198864A (en) | Auxiliary circulation apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |